跳至主要内容
临床试验/EUCTR2004-002482-20-GB
EUCTR2004-002482-20-GB进行中(未招募)不适用

A Pilot Study to Test the Effect of Treating Depression Associated with Rueumatoid Arthritis (RA) using Venlaflaxine - Venlaflaxine & Numact Study

ewcastle upon Tyne Hospitals NHS Trust0 个研究点目标入组 20 人开始时间: 2005年2月15日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Rheumatoid Arthritis(ACR criteria)
  • Male or Female Aged 18 years or over.
  • Female patients of childbearing potential must be using an adequate and reliable method of contraception whilst taking Venlaflaxine.
  • Willing and able to provide written informed consent.
  • Functional classification of II or III (ACR criteria)
  • A score > 10 on the Hospital anxiety and Depression score
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Previously Diagnosed Depression
  • Other physically disabling condition/concomitant chronic disease
  • Contraindicated use of Venlaflaxine

研究者

发起方
ewcastle upon Tyne Hospitals NHS Trust

相似试验